Examkin

Question

Difficulty: MediumNeurocognitive Disorders

A primary care physician is evaluating a 71-year-old retired mechanic who is accompanied by his son. The son reports that over the past 14 months, his father has exhibited progressive short-term memory loss, missed several bill payments, and recently struggled to recall the names of his grandchildren. The patient feels he is "doing just fine" and is mildly annoyed by the visit. Vital signs are normal, and the neurological examination is nonfocal. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for evaluating and managing this patient's suspected major neurocognitive disorder, from initial clinical assessment to definitive management.

  1. 1Administer a standardized objective cognitive screening instrument, such as the Montreal Cognitive Assessment.
  2. 2Order basic serum laboratory studies, including vitamin B12 and thyroid-stimulating hormone levels.
  3. 3Obtain structural neuroimaging, such as a non-contrast magnetic resonance imaging of the brain.
  4. 4Consider specialized investigations, such as fluorodeoxyglucose-positron emission tomography (FDG-PET) or cerebrospinal fluid analysis.
  5. 5Formulate a comprehensive care plan encompassing driving safety restrictions, advance directives, and potential pharmacological interventions.

Answer

The correct sequence begins with objective cognitive screening, followed by screening for reversible metabolic causes, obtaining structural neuroimaging, considering specialized biomarker testing if indicated, and concluding with a comprehensive management and safety plan.
The standard of care for evaluating insidious cognitive decline follows a stepwise approach designed to minimize unnecessary testing while safely ruling out reversible etiologies. The clinician must first objectively confirm the cognitive deficit (Step 1). Subsequently, easily reversible systemic, endocrine, and metabolic causes are excluded via basic laboratory testing (Step 2). Once metabolic causes are ruled out, structural neuroimaging is obtained to identify vascular changes, space-occupying lesions, or distinct neurodegenerative atrophy patterns (Step 3). If the diagnosis remains equivocal, advanced functional imaging or cerebrospinal fluid biomarker testing may be considered (Step 4). Finally, once a diagnosis is established, a comprehensive management plan addressing safety, pharmacology, and long-term care is implemented (Step 5).

Step-by-Step Solution

1
Confirm cognitive impairment.
Use of the Montreal Cognitive Assessment or Mini-Mental State Examination.
Before pursuing a costly and potentially invasive diagnostic workup, the presence and severity of cognitive deficits must be objectively established.
2
Rule out reversible metabolic or systemic causes.
Ordering vitamin B12, TSH, comprehensive metabolic panel, and complete blood count.
Hypothyroidism, vitamin B12 deficiency, and various metabolic derangements can present as pseudodementia and are easily treatable if identified early.
3
Evaluate for structural intracranial pathology.
Performing a non-contrast brain MRI (or CT).
Structural imaging rules out space-occupying lesions, normal pressure hydrocephalus, and vascular dementia while evaluating for characteristic neurodegenerative atrophy patterns.
4
Differentiate complex or atypical etiologies.
Considering FDG-PET, amyloid PET, or lumbar puncture.
If the presentation is atypical (e.g., early-onset) or the distinction between Alzheimer disease and frontotemporal dementia is unclear, specialized biomarkers are utilized.
5
Establish long-term management and safety parameters.
Discussing driving cessation, advance directives, and prescribing medications like cholinesterase inhibitors.
Appropriate medical and social management is tailored based on the definitive diagnosis reached through the preceding diagnostic cascade.

Key Concept

Diagnostic Algorithm for Major Neurocognitive Disorders
Rate this question

Topics

Neurocognitive Disorders

More questions from this topic